fda glp-1 compounding crackdown news today Despite crackdown, unapproved GLP-1s still threaten the industry The FDA's GLP-1 Compounding Crackdown

Hypothetically, antidiabetic drugs that promote weight loss or improve hyperinsulinemia are likely to lower cancer risk

Across all GLP-1 medications, 12-month persistence (still taking the medication at one year) ranges from 38% to 56% depending on the study and population (Wilding et al., Diabetes Obes Metab 2023)

The ingredients

Quicksilver Scientific Liposomal Glutathione is your top option

Using glutathione as a supplement may improve liver health in people with these conditions

Further reading Pharmacy care for thrush The results of a small-scale interview-based study, published in the British Journal of General Practice , revealed that patients and clinicians agreed that thrush could be treated effectively through community pharmacy